After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
EYPT belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of EyePoint Pharmaceuticals Inc is $496.13M. A total of 0.76 million shares were traded on the day, compared to an average of 812.33K shares.
In the most recent transaction, Zaderej Karen L. bought 5,000 shares of EYPT for 5.99 per share on May 19 ’25. After the transaction, the Director now owns 36,500 company shares. In a previous transaction on May 16 ’25, Zaderej Karen L. bought 5,000 shares at 5.81 per share. EYPT shares that Director owns now total 31,500.
Among the insiders who bought shares, Zaderej Karen L. acquired of 5,000 shares on May 15 ’25 at a per-share price of $5.47. This resulted in the Director holding 26,500 shares of EYPT after the transaction. In another insider transaction, Zaderej Karen L. bought 5,000 shares at $5.42 per share on May 14 ’25. Company shares held by the Director now total 21,500.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, EYPT has a high of $13.98 and a low of $3.91.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. EYPT’s latest balance sheet shows that the firm has $211.56M in Cash & Short Term Investments as of fiscal 2021. There were $39.20M in debt and $23.66M in liabilities at the time. Its Book Value Per Share was $4.34, while its Total Shareholder’s Equity was $184.38M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EYPT is Buy with a score of 5.00.
